Gilbert Family Foundation Funds Clinical Study to Understand Vision Loss from NF1 Optic Pathway Glioma
The Gilbert Family Foundation today announced funding of a new $5.4 million clinical study which aims to understand the mechanisms of vision loss caused by NF1-associated optic pathway gliomas, or NF1-OPGs.
Gilbert Family Foundation Collaborates with the Children’s Oncology Group and Children’s Hospital of Philadelphia to Validate a New Tool to Measure Progressive Vision Loss
The Gilbert Family Foundation today announced the launch of a clinical study that aims to validate optical coherence tomography (OCT) as a tool to objectively assess the visual system and its response to treatment in NF1 patients with optic pathway gliomas.
MSU announces Gilbert Family Foundation, Rock Family of Companies support for opening Apple Developer Academy in Detroit
Michigan State University today announced the Gilbert Family Foundation, in partnership with Rocket Companies, will support the new Apple Developer Academy in Detroit, a transformative education collaboration between Apple and MSU.
GFF and Sage Bionetworks Collaborate on an NF1 Research Tools Database
The Gilbert Family Foundation (GFF) is excited to announce the development of a database for neurofibromatosis type 1 (NF1) research tools in collaboration with Sage Bionetworks. The database aims to support the development of a robust NF1 research toolkit while also lowering the barrier of entry to research for new-to-NF1 investigators. GFF and Sage intend the database to be used by a variety of stakeholders in the NF1 research community, including researchers, drug developers, and research funders.